Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

rat IgG2a monoclonal anti-human CD44 antibody-conjugated orthopyridyl-disulfide-poly(ethylene glycol)-functionalized thiol-terminated poly(ethylene glycol)-functionalized citrate-capped gold nanoparticles aqueous solution

Based on

1 Articles
2015 Most recent source

Composition

1

citrate-stabilized gold nanoparticles

citrate-stabilized Au nanoparticles citrate-capped gold nanoparticles citrate-capped Au nanoparticles citrate-stabilized gold NP citrate-stabilized Au NP citrate-stabilized AuNP citrate-capped gold NP citrate-stabilized GNP citrate-capped Au NP citrate-capped AuNP gold nanoparticles Au nanoparticles gold NP Au NP AuNP GNP
Type Nano Material
Formula
Role core
2

orthopyridyl-disulfide-poly(ethylene glycol)

OPSS-PEG
Type Polymer
Formula
Role layer
3

IgG2a monoclonal anti-human CD44 antibody

Type Biomolecule
Formula
Role layer
4

thiol-terminated poly(ethylene glycol)

HS-PEG
Type Polymer
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
colloidal stability

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
UV-Vis-NIR optical spectroscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
human breast cancer MDA-MB-231 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
  1. 7iUIg
  2. JA3UhJA
Product

rat IgG2a monoclonal anti-human CD44 antibody-conjugated orthopyridyl-disulfide-poly(ethylene glycol)-functionalized thiol-terminated poly(ethylene glycol)-functionalized citrate-capped gold nanoparticles aqueous solution

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • IgG2a monoclonal anti-human CD44 antibody
  • orthopyridyl-disulfide-poly(ethylene glycol)-N-hydroxysuccinimide ester
  1. 6gA
  2. o7nl8umzR72AXhPXc8zjWvJIMeb3
  3. KtbF7
  4. yp5zM7
  5. Ysim8qW
Product

rat IgG2a monoclonal anti-human CD44 antibody-conjugated orthopyridyl-disulfide-poly(ethylene glycol)-functionalized thiol-terminated poly(ethylene glycol)-functionalized citrate-capped gold nanoparticles aqueous solution

Size: not specified

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • IgG2a monoclonal anti-human CD44 antibody
  • orthopyridyl-disulfide-poly(ethylene glycol)-N-hydroxysuccinimide ester
  1. sid
  2. 7lCqDFqDiMGMNIfwTV8s0pBt1fd3
  3. c4mwL
  4. bErjNB
  5. fXbX9Ke
Product

rat IgG2a monoclonal anti-human CD44 antibody-conjugated orthopyridyl-disulfide-poly(ethylene glycol)-functionalized thiol-terminated poly(ethylene glycol)-functionalized citrate-capped gold nanoparticles aqueous solution

Size: not specified

Medium/Support: none

Method 4

Type: Chemical synthesis
Source:
Starting materials
  • IgG2a monoclonal anti-human CD44 antibody
  • orthopyridyl-disulfide-poly(ethylene glycol)-N-hydroxysuccinimide ester
  1. nbo
  2. 613Jh9Fps0FGvaU9xbPSuRup2fF3
  3. K0uFv
  4. gJADzn
  5. 2Hk4P9o
Product

rat IgG2a monoclonal anti-human CD44 antibody-conjugated orthopyridyl-disulfide-poly(ethylene glycol)-functionalized thiol-terminated poly(ethylene glycol)-functionalized citrate-capped gold nanoparticles aqueous solution

Size: not specified

Medium: water

Support: none

Method 5

Type: Physical formation
Source:
  1. 2kz1R
  2. 2rhrCx1
Product

rat IgG2a monoclonal anti-human CD44 antibody-conjugated orthopyridyl-disulfide-poly(ethylene glycol)-functionalized thiol-terminated poly(ethylene glycol)-functionalized citrate-capped gold nanoparticles aqueous solution

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial